tirzepatide patent challenge Hybio Jumps as Chinese Firm Tests Lilly's US With Generic Weight-Loss Drug Filing Novo Nordisk Settles Ozempic Patent

Native GLP-1 has been infused by the subcutaneous route (4.8 pmol/kg/min) using a portable insulin pump in a non-randomized study of subjects with type 2 diabetes over the age of 40 (mean age 55) with mean initial HbA1c of about 9%, and mean fasting glucose ~14 mM

C-reactive protein is associated with sleep disordered breathing independent of adiposity

The combination of rapid weight loss, nutritional changes, and potential direct medication effects can lead to thinning hair that undermines the confidence boost patients expected from their transformation

Michael Platt My guest is Dr

Youre addicted to longevity